Skip to Content

ibr 70 mg (Imbruvica 70 mg)

Generic Name: ibrutinib

Pill with imprint ibr 70 mg is Yellow, Capsule-shape and has been identified as Imbruvica 70 mg. It is supplied by Pharmacyclics, Inc..

Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; non-hodgkin's lymphoma; mantle cell lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 70 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ibr 70 mg

Imbruvica 70 mg ibr 70 mg

Imbruvica

Generic Name
ibrutinib
Imprint
ibr 70 mg
Strength
70 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BTK inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pharmacyclics, Inc.
National Drug Code (NDC)
57962-0070

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.